Mutual Sues West-Ward Over Gout Drug Patents
Colcrys is the only oral drug containing the ingredient colchicine that has approval from the U.S. Food and Drug Administration to treat severe attacks of pain and inflammation associated with gout.
West-Ward marketed its own unapproved version of the drug for decades, but it was pulled from the market in October as part of an FDA crackdown on unapproved drugs. The...
To view the full article, register now.